Thank you very much, Madam Chair.
I would join my colleagues in thanking you for joining us today. Your testimony has really helped me in understanding some of the issues with neurological diseases and the need for research.
Mr. Walton, I want to thank you so much for sharing your personal experience with us. I want to confirm that I understand you have been living with the symptoms of ALS for approximately 14 years and then with a confirmed diagnosis of 10 years, so I can imagine that you have become a very strong advocate for raising awareness of ALS as well as for fundraising.
You also noted a concern regarding the fact that with a smaller number of individuals living with ALS as compared perhaps with those living with Parkinson's or MS, the funding dollars aren't as readily available for ALS as they might be for other studies.
I'm wondering whether, in the time you've been advocating for ALS, you're finding that the awareness has been raised and that more people are contributing to the funding for ALS.